Ultrasound Lipolysis Versus Cryolipolysis On Lipid Profile Levels In Centrally Obese Middle Aged Men

Launched by CAIRO UNIVERSITY · Oct 24, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to compare two different treatments—ultrasound lipolysis and cryolipolysis—for reducing fat and improving cholesterol levels in middle-aged men who are centrally obese. The study aims to see how these treatments affect important health markers like cholesterol, triglycerides (fats in the blood), and body measurements such as waist circumference. Essentially, it's looking at which method might be more effective for helping men in this age group manage their weight and improve their overall health.

To be eligible for this trial, participants need to be men aged between 40 and 60 who have a body mass index (BMI) over 30, indicating obesity, and a waist circumference greater than 94 cm. However, certain health conditions, such as diabetes, heart problems, or skin diseases in the belly area, would prevent someone from participating. If they join, participants can expect to undergo treatments and have their health monitored to see how these therapies improve their lipid profiles and body measurements. This study is currently not recruiting participants yet, but it aims to provide valuable information on effective weight management strategies for men dealing with central obesity.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Obese men with middle age range will be 40-60 years.
• • 2. Obese men with central obesity.
• • 3. Body mass index (BMI) greater than 30 Kg \\m2.
• • 4. Waist circumference will be \>94 cm.
• • 5. Waist to hip ratio more than 0.9
• Exclusion Criteria:
• • 1. Chronic respiratory disorders and cardiovascular problems.
• • 2. Diabetic patients.
• • 3. Presence of skin diseases in abdominal regions that prevent the use of ultra sound or cryolipolysis therapy.
• • 4. Men with kidney or liver diseases.
• • 5. Tumor diseases
• • 6. Lesions of higher center leading to obesity.
• • 7. History of active or chronic infectious, autoimmune disease.
• • 8. History of abdominal surgeries.